Please login to the form below

Not currently logged in
Email:
Password:

UK Biobank

This page shows the latest UK Biobank news and features for those working in and with pharma, biotech and healthcare.

Novartis plans inclisiran trial in the UK

Novartis plans inclisiran trial in the UK

The Swiss pharma is currently planning a primary prevention study with cholesterol-lowering drug inclisiran in the UK, building on the methods used to recruit patients into the UK Biobank. ... The UK Biobank is a national and international health

Latest news

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • #DemandDiversity: The science behind diversity #DemandDiversity: The science behind diversity

    1)   It’s been found that Black, Indian, Pakistani and Chinese participants are all underrepresented in the UK Biobank, a huge genetic database, by at least one third. ... And when this is converted to the number of times the data from an individual

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....